{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:44Z","timestamp":1789499024610,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This study aimed to investigate the reporting association between aspirin use and pregnancy-related adverse events (AEs), and to explore potential disproportionality signals for congenital disorders. A disproportionality analysis was performed using the Food and Drug Administration Adverse Event Reporting System data from Q1 2004 to Q3 2024. Four statistical approaches were applied: reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network, and empirical Bayesian geometric mean (EBGM). In addition, 2 sensitivity analyses were performed to verify the robustness of the results by excluding certain confounders. The analysis identified 1647 reports documenting aspirin-associated AEs related to pregnancy and congenital disorders. Eighty-nine high-level term signals were detected, including 19 significant disproportionality signals, with the strongest signals in each category being \u201cfetal growth complications\u201d (n\u2005=\u2005139, ROR\u2005=\u20059.89, PRR\u2005=\u20059.88, EBGM\u2005=\u20059.67, information component\u2005=\u20053.27) and \u201cvascular anomalies congenital NEC\u201d (n\u2005=\u2005282, ROR\u2005=\u200539.68, PRR\u2005=\u200539.6, EBGM\u2005=\u200536.10, information component\u2005=\u20055.17). At the preferred term level, 269 signals were identified, with 47 significant disproportionality signals. The strongest signals in their respective categories were peripartum hemorrhage (n\u2005=\u20053, ROR\u2005=\u200541.11) and cyclopia (n\u2005=\u20055, ROR\u2005=\u2005662.32). Sensitivity analyses, including adjustments for healthcare professional reports and the exclusion of patients with hypertension or gestational hypertension, confirmed the robustness of these signals. In conclusion, this large-scale pharmacovigilance study identified significant disproportionality signals for several pregnancy-related AEs and congenital disorders reported with aspirin use. While these findings provide preliminary signals for further investigation, they cannot establish causality. Clinical decisions should continue to be guided by established guidelines and evidence from randomized controlled trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049104","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:03:34Z","timestamp":1782497014000},"page":"e49104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy-related adverse events and congenital disorders associated with aspirin: A real-world pharmacovigilance analysis of the FDA adverse event reporting system"],"prefix":"10.1097","volume":"105","author":[{"given":"Zhou","family":"Fang","sequence":"first","affiliation":[{"name":"Reproductive Medicine Department, Shandong University of Traditional Chinese Medicine Second Affiliated Hospital, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xu","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Department, Shandong University of Traditional Chinese Medicine Second Affiliated Hospital, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5405-8390","authenticated-orcid":false,"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"e70167","DOI":"10.1111\/cts.70167","article-title":"Pharmacodynamics of aspirin through gestation: predictors of aspirin response and association with pregnancy outcome, a prospective cohort study.","volume":"18","author":"Boelig","year":"2025","journal-title":"Clin Transl Sci"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin.","volume":"226","author":"Rolnik","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"R3-20260915","first-page":"1","article-title":"The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention.","volume":"145","author":"Poon","year":"2019","journal-title":"In J Gynaecol Obstet"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1136\/heartjnl-2011-300949","article-title":"Hypertension in pregnancy: the NICE guidelines.","volume":"97","author":"Redman","year":"2011","journal-title":"Heart"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion no. 743: low-dose aspirin use during pregnancy.","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study.","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2105-15-17","article-title":"Large-scale combining signals from both biomedical literature and the FDA adverse event reporting system (FAERS) to improve post-marketing drug safety signal detection.","volume":"15","author":"Xu","year":"2014","journal-title":"BMC Bioinf"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jamia\/ocv063","article-title":"Use of data mining at the food and drug administration.","volume":"23","author":"Duggirala","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7150\/ijms.7967","article-title":"Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithms.","volume":"11","author":"Sakaeda","year":"2014","journal-title":"Int J Med Sci"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40264-025-01524-x","article-title":"Are causal statements reported in pharmacovigilance disproportionality analyses using individual case safety reports exaggerated in related citations? A meta-epidemiological study.","volume":"48","author":"Bernardeau","year":"2025","journal-title":"Drug Saf"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. preventive services task force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222.","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/AOG.0000000000005517","article-title":"Aspirin in pregnancy.","volume":"143","author":"Hoffman","year":"2024","journal-title":"Obstet Gynecol"},{"key":"R15-20260915","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications.","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1055\/a-2096-5199","article-title":"Low-dose aspirin during pregnancy and postpartum bleeding.","volume":"40","author":"White","year":"2023","journal-title":"Am J Perinatol"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2023.0691","article-title":"Aspirin discontinuation at 24 to 28 weeks\u2019 gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial.","volume":"329","author":"Mendoza","year":"2023","journal-title":"JAMA"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"e055924","DOI":"10.1136\/bmj-2021-055924","article-title":"Management and outcomes of extreme preterm birth.","volume":"376","author":"Morgan","year":"2022","journal-title":"BMJ"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial.","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia.","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/uog.19077","article-title":"Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.drudis.2020.05.011","article-title":"Prophylactic aspirin for preventing pre-eclampsia and its complications: an overview of meta-analyses.","volume":"25","author":"Ghazanfarpour","year":"2020","journal-title":"Drug Discov Today"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","article-title":"Aspirin resistance.","volume":"367","author":"Hankey","year":"2006","journal-title":"Lancet"},{"key":"R25-20260915","first-page":"334","article-title":"Aspirin resistance may be associated with adverse pregnancy outcomes.","volume":"32","author":"W\u00f3jtowicz","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. preventive services task force.","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00019605-200207000-00018","article-title":"Cyclopia-astomia-agnathia-holoprosencephaly association: a case report.","volume":"11","author":"Sezgin","year":"2002","journal-title":"Clin Dysmorphol"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/15513818609037721","article-title":"Cyclopia and maternal ingestion of salicylates.","volume":"6","author":"Agapitos","year":"1986","journal-title":"Pediatr Pathol"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jez.1402160111","article-title":"Aspirin-induced teratogenesis: a unique pattern of cell death and subsequent polydactyly in the rat.","volume":"216","author":"Klein","year":"1981","journal-title":"J Exp Zool"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1096-9926(199710)56:4<241::AID-TERA2>3.0.CO;2-1","article-title":"Prenatal exposure to salicylates and gastroschisis: a case-control study.","volume":"56","author":"Mart\u00ednez-Fr\u00edas","year":"1997","journal-title":"Teratology"},{"issue":"Suppl 3","key":"R31-20260915","first-page":"1","article-title":"Safety assessment of salicylic acid, butyloctyl salicylate, calcium salicylate, C12-15 alkyl salicylate, capryloyl salicylic acid, hexyldodecyl salicylate, isocetyl salicylate, isodecyl salicylate, magnesium salicylate, MEA-salicylate, ethylhexyl salicylate, potassium salicylate, methyl salicylate, myristyl salicylate, sodium salicylate, TEA-salicylate, and tridecyl salicylate.","volume":"22","year":"2003","journal-title":"Int J Toxicol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:11:21Z","timestamp":1789495881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":30,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049104","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2025-12-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}